A broad in vivo screen of the effects of specific gene inhibition on the antitumour activity of immune cells in mice bearing melanomas has revealed potential targets for cancer therapy. See Article p.52
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhou, P. et al. Nature 506, 52–57 (2014).
Hodi, F. S. et al. N. Engl. J. Med. 363, 711–723 (2010).
Topalian, S. L. et al. N. Engl. J. Med. 366, 2443–2454 (2012).
Robert, C. et al. N. Engl. J. Med. 364, 2517–2526 (2011).
Zender, L. et al. Cell 135, 852–864 (2008).
Berns, K. et al. Cancer Cell 12, 395–402 (2007).
Meacham, C. E., Ho, E. E., Dubrovsky, E., Gertler, F. B. & Hemann, M. T. Nature Genet. 41, 1133–1137 (2009).
Bric, A. et al. Cancer Cell 16, 324–335 (2009).
Guo, L. et al. Proc. Natl Acad. Sci. USA 110, E1849–E1856 (2013).
Wuestefeld, T. et al. Cell 153, 389–401 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zender, L. Interference identifies immune modulators. Nature 506, 39–40 (2014). https://doi.org/10.1038/nature13050
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature13050
